ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
0 hedge funds and large institutions have $0 invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2022 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
1.36% less ownership
Funds ownership: 1.36% → 0% (-1.4%)
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $497K → $0 (-$497K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMC Chicago
Chicago,
Illinois
|
-$497K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
IMC Chicago
Chicago,
Illinois
| – | -$497K | -13,614 | Closed |
|
IWFL Hedge Fund Activity: Q1 2022 in Review
0 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q1 2022, worth a combined $0 — down 100% from $497K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IWFL and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was IMC Chicago, exiting entirely with an estimated $497K sold.
- 0 institutional investors held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q1 2022, down from 1 in Q4 2021.
- Funds reported $0 of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q1 2022, down 100% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN seller in Q1 2022 was IMC Chicago, an estimated $497K sold.
Based on aggregated 13F filings for Q1 2022.